Nima Sharifi, MD of Cleveland Clinic discusses the new Androgen Receptor Signaling and the new targets and agents for advanced prostate cancer at ASCO GU 2016 in San Francisco.
Advertisement
New Androgen Receptor Signaling and the new targets and agents for advanced prostate cancer
By Editor